Evolent Health
EVH
242 hedge funds and large institutions have $1.16B invested in Evolent Health in 2025 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 72 increasing their positions, 78 reducing their positions, and 31 closing their positions.
79% more call options, than puts
Call options by funds: $2.88M | Put options by funds: $1.61M
71% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 31
23% more capital inflows, than outflows
Capital inflows: $241M | Capital outflows: $196M
9% more funds holding
Funds holding: 222 → 242 (+20)
4.47% more ownership
Funds ownership: 112.17% → 116.64% (+4.5%)
8% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 78
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$22.6M |
| 2 |
Eventide Asset Management
Boston,
Massachusetts
|
+$21.4M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$16.6M |
| 4 |
Jane Street
New York
|
+$14M |
| 5 |
Cadian Capital Management
New York
|
+$12.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Durable Capital Partners
Bethesda,
Maryland
|
-$72.3M |
| 2 |
Goldman Sachs
New York
|
-$21.6M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$16.5M |
| 4 |
8KM
8 Knots Management
Dallas,
Texas
|
-$11.1M |
| 5 |
Barclays
London,
United Kingdom
|
-$8.93M |
EVH Hedge Fund Activity: Q3 2025 in Review
242 of the 7,661 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q3 2025, worth a combined $1.16B — down 22% from $1.48B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new EVH positions and 31 closed out — a net gain of 22 holders — while 72 added to existing stakes and 78 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $22.6M. The largest seller was Durable Capital Partners, exiting entirely with an estimated $72.3M sold.
- 242 institutional investors held Evolent Health (EVH) as of Q3 2025, up from 222 in Q2 2025.
- Funds reported $1.16B of Evolent Health stock for Q3 2025, down 22% quarter-over-quarter.
- 53 funds opened new Evolent Health positions in Q3 2025 and 31 closed out, a net change of +22 holders.
- The largest Evolent Health buyer in Q3 2025 was Fidelity Investments, an estimated $22.6M added.
- The largest Evolent Health seller in Q3 2025 was Durable Capital Partners, an estimated $72.3M sold.
Based on aggregated 13F filings for Q3 2025.